期刊文献+

经皮迷走神经刺激术的临床应用进展 被引量:7

下载PDF
导出
摘要 20世纪80年代中期出现的植入式迷走神经刺激术(inva-sivevagusnervestimulation,i-VNS)不仅是治疗难治性癫痫的有效方案,还被应用于抑郁症等的治疗。但其也有很多不足之处,如不良反应较多,需要进行有创性手术、价格昂贵等。2000年加拿大学者提出用经皮电刺激耳部迷走神经分布区的方法——经皮迷走神经刺激术(transcutaneousvagusnervestimula.tion,t-VNS)治疗难治性癫痫。该方法能够在保留i-VNS有效性的基础上,避免有创性手术且不良反应较少。本文对t-VNS近几年的发展进行综述如下。
作者 宋璐 刘爱华
出处 《疑难病杂志》 CAS 2013年第10期809-811,共3页 Chinese Journal of Difficult and Complicated Cases
  • 相关文献

参考文献4

二级参考文献45

  • 1黄宗勖.针药并治癫痫54例临床疗效观察[J].福建中医学院学报,1993,3(1):7-9. 被引量:4
  • 2Dichter MA. Innovative clinical trial designs for future antiepileptic drugs. Epilepsia, 2007, 48 Suppl 1 : 26-30.
  • 3Kwan P, Brodie MJ. Early identification of refractory epilepsy. N End J Med. 2000. 342: 314-319.
  • 4Musicco M, Beghi E, Solari A, et al. Treatment of first tonicelonie seizure does not improve the prognosis of epilepsy. First Seizure Trial Group ( FIRST Group). Neurology, 1997,49 : 991- 998.
  • 5Camfield P, Camfield C, Smith S, et al. Long-term outeome is unchanged by antiepileptic drug treatment after a first seizure: a 15-year follow-up from a randomized trial in childhood. Epilepsia, 2002, 43: 662-663.
  • 6Dlugos DJ, Sammel MD, Strom BL, et al. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology, 2001, 57: 2259-2264.
  • 7Brodie M J, Kwan P. Staged approach to epilepsy management. Neurology, 2002, 58: S2--8.
  • 8Berg AT, Vickrey BG, Testa FM, et al. How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol, 2006, 60 : 73-79.
  • 9Beghi E, Gatti G, Tonini C, et al. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res, 2003, 57: 1-13.
  • 10Deckers CL. Place of polytherapy in the early treatment of epilepsy. CNS Drugs, 2002, 16: 155-163.

共引文献14

同被引文献53

  • 1冯周琴,徐军,党雷,马建军,苗雪梅,史锡文,刘芳.刺激迷走神经治疗癫痫的实验研究与临床观察[J].河南医学研究,1995,4(1):3-6. 被引量:8
  • 2范修云,陈雨娜.心理干预对不稳定型心绞痛伴抑郁症的疗效[J].实用医学杂志,2007,23(17):2686-2687. 被引量:13
  • 3Jones E, Eteiba W, Merz NB. Cardiac syndrome X and microvascular coronary dysfunction [J].Trends Cardiac Med, 2012,22(6):161-168.
  • 4Recio-Mayoral A,Rimoldi OE,Camici PG,et al. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease [J]. JACC Cardiovasc Imaging,2013,6(6):660-667.
  • 5Lim TK,Chov AJ,Khan F,et al.Therapentic development in cardiac syndrome X: a need to target the underlying pathophysiology[J].Cardiovasc Ther, 2009,27(1):49:58.
  • 6Mukesh Singh,Sarabjeet Singh,Rohit Arora,et al. Cardiac syndrome X: current concepts [J]. International Journal of Cardiology, 2010,142(2):113-119.
  • 7Gaetano Antonio Lanza, Filippo Crea. Primary coronary microvascular dysfunction: clinlical presentation,pathophysiology, and management[J]. Circulatioin,2010,121(21):2317-2325. 2013,15(9):2011-2020.
  • 8Mtiller K,Fab6 D,Entz L,et al.Outcome of vagus nerve stimulation for epilepsy in Budapest [J].Epilepsia,2010,51 (3): 98-101.
  • 9Cers6simo RO,Bartuluchi M,Fortini S,et al. Vagus nerve stimulation:effectiveness and tolerability in 64 paediatric patients with refractory epilepsies [J].Epileptic Disord, 2011,13 (4):382-388.
  • 10Rong PJ,Fang JL,Wang LP,et al. Transcutaneous vagus nerve stimulation for the treatment of depression:a study protocol for a double blinded randomized clinical trial [J].BMC Complement Altern Med, 2012,14(3):255-257.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部